Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Chamberlain

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Investigational New Drugs|July 6, 2026
A first-in-human phase 1a study of LP-184, a tumor-site activated novel alkylating agent, in patients with advanced solid tumorsDaruka Mahadevan, Jay Parekh, Joseph T Beck, et al.
Neuro-Oncology|January 8, 2019
PET imaging in patients with brain metastasis-report of the RANO/PET groupNorbert Galldiks, Karl-Josef Langen, Nathalie L Albert, et al.
Journal for Immunotherapy of Cancer|March 13, 2025
Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancerOladapo O Yeku, Minal Barve, Winston W Tan, et al.
Neurology|October 11, 2013
Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group reportJennie W Taylor, Eoin P Flanagan, Brian P O'Neill, et al.
Neuro-Oncology|March 14, 2020
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastomaVinay K Puduvalli, Jing Wu, Ying Yuan, et al.
Neuro-Oncology|September 22, 2016
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trialsEdward K Avila, Marc Chamberlain, David Schiff, et al.
Neuro-Oncology|April 17, 2018
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastomaBenjamin M Ellingson, Dana T Aftab, Gisela M Schwab, et al.
Neuro-Oncology|April 29, 2017
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteriaLakshmi Nayak, Lisa M DeAngelis, Alba A Brandes, et al.
Neuro-Oncology Advances|December 30, 2024
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastomaJoe S Mendez, Adam L Cohen, Midori Eckenstein, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Investigational New Drugs|July 6, 2026
A first-in-human phase 1a study of LP-184, a tumor-site activated novel alkylating agent, in patients with advanced solid tumorsDaruka Mahadevan, Jay Parekh, Joseph T Beck, et al.
Neuro-Oncology|January 8, 2019
PET imaging in patients with brain metastasis-report of the RANO/PET groupNorbert Galldiks, Karl-Josef Langen, Nathalie L Albert, et al.
Journal for Immunotherapy of Cancer|March 13, 2025
Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancerOladapo O Yeku, Minal Barve, Winston W Tan, et al.
Neurology|October 11, 2013
Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group reportJennie W Taylor, Eoin P Flanagan, Brian P O'Neill, et al.
Neuro-Oncology|March 14, 2020
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastomaVinay K Puduvalli, Jing Wu, Ying Yuan, et al.
Neuro-Oncology|September 22, 2016
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trialsEdward K Avila, Marc Chamberlain, David Schiff, et al.
Neuro-Oncology|April 17, 2018
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastomaBenjamin M Ellingson, Dana T Aftab, Gisela M Schwab, et al.
Neuro-Oncology|April 29, 2017
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteriaLakshmi Nayak, Lisa M DeAngelis, Alba A Brandes, et al.
Neuro-Oncology Advances|December 30, 2024
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastomaJoe S Mendez, Adam L Cohen, Midori Eckenstein, et al.
Pageof 4